Facilitating Access to a COVID-19 Vaccine through Global Health Law

B.S. Graham , “Rapid COVID-19 Vaccine Development” Science 368, no. 6494 (2020): 945-946.

S. Moon et al., “Global Public Goods For Health: Weaknesses and Opportunities in the Global Health System,” Health, Economics, Policy and Law 12, no. 2 (2017): 195-205.

M. Cueto et al., The World Health Organization: A History (Cambridge University Press, 2019).

G. Makenga et al., “Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable Vaccine Introduction,” Frontiers in Public Health (2019), available at <https://www.frontiersin.org/articles/10.3389/fpubh.2019.00056/full> (last visited August 19, 2020).

A. Usher , “COVID-19 Vaccines For All?” The Lancet 395, no. 10240 (2020): 1822-1823.

T.M. Bollyky , L.O. Gostin , and M.A. Hamburg , “The Equitable Distribution of COVID-19 Therapeutics and Vaccines,” JAMA 323, no. 24 (2020): 2462-2463, doi: 10.1001/jama.2020.6641.

L. O. Gostin and B. M. Meier , Foundations of Global Health & Human Rights (Cambridge University Press, 2020).

P. Ball , “Anti-Vaccine Movement Could Undermine Efforts to End Coronavirus Pandemic, Researchers Warn,” Nature 581 (2020): 251, available at <https://www.nature.com/articles/d41586-020-01423-4> (last visited August 19, 2020).

United Nations, Committee on Economic, Social and Cultural Rights, Substantive issues arising in the implementation of the International Covenant on Economic, Social and Cultural Rights: General Comment No. 14, Geneva: United Nations; 2000, U.N. Doc. E/C.12/2000/4.

United Nations. Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. Promotion and protection of human rights: human rights questions, including alternative approaches for improving the effective enjoyment of human rights and fundamental freedoms; Sept. 13, 2006, UN Doc. A/61/338.

United Nations,, Committee on Economic, Social and Cultural Rights, General comment No. 25 (2020) on science and economic, social and cultural rights (article 15 (1) (b), (2), (3) and (4) of the International Covenant on Economic, Social and Cultural Rights), Geneva: United Nations; 2020, U.N. Doc. E/C.12/GC/25.

B. M. Meier , A.e Gelpi , M.M. Kavanagh , L. Forman , and J.J. Amon , “Employing Human Rights Frameworks to Realize Access to an HIV Cure,” Journal of the International AIDS Society 18, no. 1 (2015): 1-7.

United Nations, supra note 9, para. 31.

Id., para. 12.

A. Usher , “COVID-19 Vaccines For All?” The Lancet 395, no. 10240 (2020): 1822-1823, available at <https://doi.org/10.1016/S0140-6736(20)31354-4> (last visited August 19, 2020).

J.C. Capretta , “The Fragile Vaccine Plan to Save the World: The Fast-Moving Partnership Between Governments and Philanthropy Merits U.S. Backing,” The Bulwark, July 29, 2020, available at <https://thebulwark.com/the-fragile-vaccine-plan-to-save-the-world/> (last visited August 19, 2020).

World Health Organization, Pandemic Influenza Preparedness (PIP) Framework, available at <https://www.who.int/influenza/pip/en/> (last visited August 19, 2020).

“Global Governance for COVID-19 Vaccines,” The Lancet 395 (2020): 1883.

R.P. Petchesky , Global Prescriptions: Gendering Health and Human Rights (Zed Books, 2006).

M.D. Islam , W.A. Kaplan , D. Trachtenberg , et al., “Impacts of Intellectual Property Provisions in Trade Treaties on Access to Medicine in Low and Middle Income Countries: A Systematic Review,” Global Health 15, no. 1 (2019): 88-102.

WHO Regional Office for South-East Asia, 23rd Meeting of Health Ministers of Countries of SEAR, “Access to Medicines and Vaccines: Implications of Intellectual Property Protection and Trade Agreements” SEA/HMM/Meet23/5 (August 18, 2005).

“The Medicines Patent Pool,” Unitaid, July 29, 2019), available at <https://unitaid.org/project/medicines-patent-pool> (last visited August 19, 2020).

K. Perehudoff and K. Sellin , “COVID-19 Technology Access Pool (C-TAP): A Promising Human Rights Approach,” Health and Human Rights Blog, available at <https://www.hhrjournal.org/2020/06/covid-19-technology-access-pool-c-tap-a-promising-human-rights-approach/> (last visited August 19, 2020).

World Health Organisation, “COVID-19 technology access pool,” available at <https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/covid-19-technology-access-pool> (last visited August 19, 2020).

M. Moran , et al., “Registering New Drugs for Low-Income Countries: The African Challenge,” PLoS Medicine 8, no. 2 (2011): e1000411.

T.B. Ghedamu and B.M. Meier , “Assessing National Public Health Law to Prevent Infectious Disease Outbreaks: Immunization Law as a Basis for Global Health Security,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 412-426.

N. Dellepiane and D. Wood , “Twenty-Five Years of the WHO Vaccines Prequalification Programme (1987–2012): Lessons Learned and Future Perspectives,” Vaccine 33, no. 1 (2015): 52-61.

World Health Organisation, “Prequalification,” available at <https://www.who.int/rhem/prequalification/en/> (last visited August 19, 2020).

P. Duclos , “National Immunization Technical Advisory Groups (NITAGs): Guidance for Their Establishment and Strengthening,” Vaccine 28, Suppl. 1 (2010): A18-25.